drugset / Trial / NCT07396584
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
Timeline
- Start
- 2026-03-04
- Primary completion
- 2028-12-31
- Completion
- 2029-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HMPL-A580 | Unknown | — | — |
Indications
No indication recorded.